RxDoctor Payments Data

John Gilbert, DO

Otolaryngology/Facial Plastic Surgery · Elkhart, INNPI 1275735581

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (58.3%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Spirair, Inc. accounts for 62.8% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $16,865, 8.7 times the $1,938 reported in 2019.

$24,353in general payments, 2019–2025

Across 166 payments — averaging $146.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spirair, Inc.$15K
  • Aerin Medical Inc.$4K
  • Stryker$2K
  • Acclarent, Inc$899
  • Medtronic$437
  • Integra Lifesciences Corporation$419
  • plus $2K from 16 others
$50,960in research payments, 2019–2025

Across 8 payments — averaging $6369.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$51K

What the payments were for

  • Consulting fees$14,20058%
  • Speaking & faculty fees$8003%
  • Travel & lodging$3401%
  • Food & beverage$8,97937%
  • Education$340%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in Indianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$155,553
Medicare patients
323
Services billed
1,219

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab15$59,967
Ipratropium Bromide203$5,000
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth11$1,293
Azelastine Hcl39$1,249
CefuroximeCefuroxime Axetil53$1,070
Tobramycin-DexamethasoneTobramycin/Dexamethasone13$755
Doxycycline Hyclate29$444
Ofloxacin20$424
Mupirocin63$386
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav36$354
Cefdinir19$328
Triamcinolone Acetonide20$190
Fluticasone Propionate19$178
Methylprednisolone34$153
Prednisone60$151

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Elkhart

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →